Unlock instant, AI-driven research and patent intelligence for your innovation.

Mass preparation of SARS virus capable of meeting the production of inactivated vaccine and inactivation method

A SARS virus and inactivation technology, applied in the field of SARS virus liquid, can solve problems such as danger

Inactive Publication Date: 2007-05-30
SINOVAC BIOTECH
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the prepared, massive, and high-concentration SARS virus, especially live virus, is filtered and harvested, which is extremely dangerous in the process of vaccine production and operation.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Mass preparation of SARS virus capable of meeting the production of inactivated vaccine and inactivation method
  • Mass preparation of SARS virus capable of meeting the production of inactivated vaccine and inactivation method
  • Mass preparation of SARS virus capable of meeting the production of inactivated vaccine and inactivation method

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0032]Example 1 Preparation of Stromal Cell Scale Working Seed Batch

[0033] 1) Take one main seed of the human embryonic lung diploid cell 2BS strain that meets the vaccine production requirements, resuscitate routinely, passage to 24-30 passages, inoculate with CF10, digest in a single layer, make a cell suspension, and centrifuge (800- 1000rpm), discard the supernatant, and adjust the cell concentration to 10 after suspending the cells with the cell freezing medium 6 ~10 7 After / ml, add DMSO and mix evenly, and distribute into cryopreservation tubes, 1.0-2.0ml / tube.

[0034] 2) Take one branch of the main seed of human embryonic lung diploid cell MRC-5 strain that meets the requirements for vaccine production, routinely resuscitate, subculture to 24-30 generations, inoculate with CF10, digest in a single layer, make a cell suspension, and centrifuge ( 800~1000rpm), discard the supernatant, suspend the cells with cell freezing medium, adjust the cell concentration to 10 ...

Embodiment 2

[0037] Example 2 Preparation of Working Cell Batches of Stromal Cells

[0038] 1) Preparation of working cell batches of human embryonic lung diploid cells 2BS strain

[0039] Take one working seed of the human embryonic lung diploid cell 2BS strain described in Example 1, resuscitate through the conventional cell resuscitation process as shown in Figure 2, and conventionally (1:2~1:4) for 4 to 5 consecutive passages , spread to 8-16 10-layer (or 2-4 40-layer) cell factories (cultivation area up to 50560-101120cm 2 / batch, equivalent to 40~80 3000ml cell culture spinner bottles), used for inoculating SARS virus.

[0040] 2) Preparation of working cell batches of human embryonic lung diploid cells MRC-5 strain

[0041] Take 1 working seed of the human embryonic lung diploid cell MRC-5 strain described in Example 1, resuscitate through the conventional cell resuscitation process as shown in Figure 2, and conventionally (1:2~1:4) for 4 to 4 consecutive passages. 5 times, sprea...

Embodiment 3

[0044] Example 3 Conventional isolation method of SARS virus in clinical SARS patient specimen

[0045] Specific steps are as follows:

[0046] (1) Stool suspension (5%); and / or

[0047] (2) Throat swab 1-2ml (original times);

[0048] (3) Sterilization: After 0.22um filtration, add 10-20% PS and mix well, then overnight at 4°C;

[0049] (4) Inoculation: 25cm 2 After washing the monolayer cells, inoculate the sterilized sample (1-2 bottles, 1-2ml / bottle);

[0050] (5) Adsorption: Adsorb at 37°C for 1-4 hours, add maintenance solution to 10ml / bottle;

[0051] (6) Cultivation: constant temperature cultivation at 33-37°C;

[0052] (7) Observation: Directly observe cell lesions under a microscope, and record the earliest time, type and degree of lesions in detail;

[0053] (8) Harvest: Harvest the obtained virus samples in different ways according to the presence or absence of lesions:

[0054] a) No disease: If there is no disease after 3-5 consecutive generations of blind...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a SARS virus scaled preparation and deactivation method, and SARS virus liquid prepared through the method. The prepared SARS virus can be applied into the scaled production for SARS virus inactivated vaccine.

Description

field of invention [0001] The invention relates to a method for large-scale preparation and inactivation of SARS virus that can satisfy the production of inactivated vaccines, and a SARS virus liquid prepared by the method. Background of the invention [0002] In order to prevent the spread of Severe Acute Respiratory Syndrome (Severe Acute Respiratory Syndrome, hereinafter referred to as SARS) in my country and even the whole world, there is an urgent need for a SARS virus vaccine that can effectively prevent the disease. [0003] In terms of vaccine types, it can be mainly divided into genetically engineered vaccines that use specific virus surface antigens obtained by genetic engineering methods or their fragments to trigger immune responses, such as genetically engineered hepatitis B virus vaccines; vaccines prepared by using attenuated viruses Live attenuated vaccines, such as live attenuated measles vaccines; and inactivated vaccines prepared from live virus strains af...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N7/00C12N7/04A61K39/215A61P31/14A61P11/00
Inventor 刘瑜瑄张建三黄金凤刘玉芬裴艳茹张小梅胡伟韦志华韩中山高强赵伟尹卫东
Owner SINOVAC BIOTECH